Oral Cancer Treatment Market Research Report – Global Forecast till 2023

Oral Cancer Treatment Market Research Report – Global Forecast till 2023

ID: MRFR/HC/1288-HCRR | January, 2018 | Region: Global | 90 pages | Half-Cooked Research Reports

Oral Cancer Treatment Market Research Report, By Type (Squamous Cell Carcinoma, Minor Salivary Gland Carcinomas), By Treatment (Surgery, Radiotherapy, Chemotherapy), By End Users (Research Organization, Academic Institutes) - Global Forecast till 2023 


Market Scenario


Cancer is defined as the uncontrolled growth of the cells that can invade and damage the surrounding cells. Oral cancer or mouth cancer is a type of cancer that effects the oral cavity. A sore of mouth that is not going away, can be an indication of oral cancer. Various types of oral cancers are inclusive of squamous cell carcinoma, verrucous carcinoma, minor salivary gland carcinomas, lymphomas, and others. However, a majority of the reported cases of oral cancer is restricted to the squamous cell carcinoma. Increasing prevalence of oral cancer, rising per capita healthcare expenditures, and growing awareness about oral diseases are some of the major drivers for the market growth during the forecast period. In 2017, according to the Oral Cancer Foundation, 49,750 Americans are estimated to be diagnosed with the oral oropharyngeal cancer. Moreover, it is estimated that 9,750 deaths will be accounted for the same, killing one patient every 24 hours. Additionally, in 2015, according to the Centres for Disease Control and Prevention, in the U.S., the total healthcare expenditure accounted for 17.8% of the total gross domestic product (GDP), which accounted for USD 3.2 trillion. However, risks of recurrence of cancer even after the treatment and related side effects followed by high cost of treatment are some of the restraints of the market growth. According to the Dharamshila Hospital, India in 2015, the cost of the treatment of the oral cancers can range from USD 2,995 to USD 14,979. 


The global oral cancer treatment market is expected to grow at an approximate CAGR of 7.1% during the forecast period. 


Intended Audience



  • Healthcare companies

  • Biotechnological institutes

  • Research and Development (R&D) Companies

  • Medical Research Laboratories

  • Market Research and Consulting Service Providers 


Figure 1:- Global oral cancer treatment market share, by region

Oral Cancer Treatment Market


Sources: WHO, annual reports, press release, white paper, and company presentation


 


Segmentation


The global oral cancer treatment market is segmented on the basis of type, treatment, and end users.


On the basis of type, the market is segmented into squamous cell carcinoma, verrucous carcinoma, minor salivary gland carcinomas, lymphomas, and others.


On the basis of treatment, the market is segmented into surgery, radiotherapy, chemotherapy, and photodynamic therapy (PDT), and others. The surgery segment is sub segmented into tumor resection, glossectomy, laryngectomy, mohs micrographic surgery, and others. The chemotherapy segment is sub segmented into cisplatin, carboplatin, 5-fluorouracil (5-FU), and others.


On the basis of end users, the market is segmented into hospitals & clinics, research organization, academic institutes, and others. 


Regional Analysis 


The Americas dominates the global oral cancer treatment market. A well-developed healthcare sector and rising per capita healthcare expenditures facilitate the market growth within the region during the forecast period. Moreover, high prevalence of oral cancer drives the growth of the market in America. Additionally, the presence of developed economies like the U.S. and Canada in the Americas fuels the market growth. 


Europe is the second largest market for oral cancer treatment. Availability of funds for research, a well-developed healthcare infrastructure, huge patient population, rising healthcare expenditure drives the market growth within the region. In 2014, according to the Cancer Research U.K, 11,449 new cases of oral cancer were reported which caused 2,386 estimated death within the same year.


Asia Pacific is the fastest growing region for the market. The presence of huge patient population and developing economies like India and China within the region facilitates the market growth. This along with favourable government policies will boost the market growth in the presence of huge opportunities for the untapped market. 


The Middle East & Africa has the least share in the global oral cancer treatment market due to the presence of poor economies and stringent government policies especially in the African region. Majority of the market of the Middle & Africa region is held by the Middle East due to huge healthcare expenditures by the presence of the developed economies like Saudi Arabia, Kuwait and Qatar within the region. 


Research Methodology


Global Oral Cancer Treatment Market


Sources: WHO, annual reports, press release, white paper, and company presentation 


 


Key players for global oral cancer treatment market


The key players for the global oral cancer treatment market are Bristol-Myers Squibb Company (U.S.) Qilu Pharmaceutical Co., Ltd. (Asia Pacific), Teva Pharmaceutical Industries Ltd. (Isarael), Eli Lilly and Company. (U.S.), F. Hoffmann-La Roche Ltd (Europe), Merck & Co., Inc. (U.S.), Novartis AG (Europe), Pfizer Inc. (U.S.), and others.



TABLE OF CONTENT    

Chapter 1.    Report Prologue    

Chapter 2.    Market Introduction    


      2.1    Definition    

      2.2    Scope of the Study    

            2.2.1    Research Objective    

            2.2.2    Assumptions    

            2.2.3    Limitations    

Chapter 3.    Research Methodology

      3.1    Introduction

      3.2    Primary Research    

      3.3    Secondary research    

      3.4    Market Size Estimation

Chapter 4.    Market Dynamics

      4.1    Drivers    

      4.2    Restrains

      4.3    Opportunities    

      4.4    Challenges

      4.5    Macroeconomic Indicators

      4.6    Technology Trends & Assessment            

Chapter 5.    Market Factor Analysis

      5.1    Porters Five Forces Analysis

            5.1.1    Bargaining Power of Suppliers    

            5.1.2    Bargaining Power of Buyers

            5.1.3    Threat of New Entrants    

            5.1.4    Threat of Substitutes    

            5.1.5    Intensity of Rivalry    

      5.2    Value Chain Analysis

      5.3    Investment Feasibility Analysis    

      5.4    Pricing Analysis

Chapter 6.    Global Oral Cancer Treatment Market, by Type

     6.1    Introduction

      6.2    Squamous Cell Carcinoma

Market Estimates & Forecast, 2017 – 2023

      6.3    Verrucous Carcinoma

Market Estimates & Forecast, 2017 – 2023

    6.4    Minor Salivary Gland Carcinomas

        Market Estimates & Forecast, 2017 – 2023    

      6.5    Lymphomas

Market Estimates & Forecast, 2017 – 2023    

      6.6    Others



Chapter 7.    Global Oral Cancer Treatment Market, by Treatment

     7.1    Introduction

      7.2    Surgery

Market Estimates & Forecast, 2017 – 2023

            7.2.1    Tumor Resection

            7.2.2    Glossectomy

            7.2.3    Laryngectomy

            7.2.4    Mohs Micrographic Surgery

            7.2.5    Others

      7.3    Radiotherapy

Market Estimates & Forecast, 2017 – 2023

      7.4    Chemotherapy

Market Estimates & Forecast, 2017 – 2023

            7.4.1    Cisplatin

            7.4.2    Carboplatin

            7.4.3    5-fluorouracil (5-FU)

            7.4.4    Others

      7.5    Photodynamic Therapy (PDT)

Market Estimates & Forecast, 2017 – 2023

      7.6    Others



Chapter 8.    Global Oral Cancer Treatment Market, by End Users

      8.1    Introduction

      8.2    Hospitals & Clinics

Market Estimates & Forecast, 2017 – 2023

      8.3    Research Organization

Market Estimates & Forecast, 2017 – 2023

      8.4    Academic Institutes

Market Estimates & Forecast, 2017 – 2023

      8.5    Others

Chapter 9.    Global Oral Cancer Treatment Market, by Region

      9.1    Introduction

      9.2    America

            9.2.1    North America

                9.2.1.1    US

                9.2.1.2    Canada

            9.2.2    South America

      9.3    Europe

            9.3.1    Western Europe

                9.3.1.1    Germany

                9.3.1.2    France

                9.3.1.3    Italy

                9.3.1.4    Spain

                9.3.1.5    U.K

                9.3.1.6    Rest of Western Europe

            9.3.2    Eastern Europe

      9.4    Asia Pacific

            9.4.1    Japan

            9.4.2    China

            9.4.3    India

            9.4.4    Australia

            9.4.5    Republic of Korea

            9.4.6    Rest of Asia Pacific

      9.5    The Middle East & Africa

            9.5.1    United Arab Emirates

            9.5.2     Saudi Arabia

            9.5.3    Oman

            9.5.4    Kuwait

            9.5.5    Qatar

            9.5.6    Rest of the Middle East & Africa

Chapter 10.    Company Landscape    

      10.1    Introduction    

      10.2    Market Share Analysis    

      10.3    Key Development & Strategies    

            10.3.1    Key Developments    

Chapter 11    Company Profiles    

      11.1    Bristol-Myers Squibb Company

            11.1.1    Company Overview    

            11.1.2    Product Overview    

            11.1.3    Financials

            11.2.4    Key Developments    

            11.1.5    SWOT Analysis    

      11.2    Qilu Pharmaceutical Co., Ltd.

            11.2.1    Company Overview    

            11.2.2    Product Overview    

            11.2.3    Financial Overview    

            11.2.4    Key Developments    

            11.2.5    SWOT Analysis    

      11.3    Teva Pharmaceutical Industries Ltd.

            11.3.1    Company Overview    

            11.3.2    Product Overview    

            11.3.3    Financial Overview

            11.3.4    Key Development    

            11.3.5    SWOT Analysis    

      11.4    Eli Lilly and Company.

            11.4.1    Company Overview    

            11.4.2    Product/Business Segment Overview    

            11.4.3    Financial Overview    

            11.4.4    Key Development    

            11.4.5    SWOT Analysis    

      11.5    F. Hoffmann-La Roche Ltd 

            11.5.1    Company Overview    

            11.5.2    Product Overview    

            11.5.3    Financial overview    

            11.5.4    Key Developments    

            11.5.5    SWOT Analysis    

      11.6    Merck & Co., Inc.

            11.6.1    Company Overview    

            11.6.2    Product Overview    

            11.6.3    Financial Overview    

            11.6.4    Key Developments    

            11.6.5    SWOT Analysis    

      11.7    Novartis AG

            11.7.1    Overview    

            11.7.2    Product Overview    

            11.7.3    Financials    

            11.7.4    Key Developments    

            11.7.5    SWOT Analysis    

    11.8    Pfizer Inc.

            11.8.1    Overview    

            11.8.2    Product Overview    

            11.8.3    Financials    

            11.8.4    Key Developments    

            11.8.5    SWOT Analysis    

      11.9    Others

Chapter 12    MRFR Conclusion    

      12.1    Key Findings    

            12.1.1    From CEO’s View Point    

            12.1.2    Unmet Needs of the Market    

      12.2    Key Companies to Watch    

      12.3    Prediction of Oral Cancer Industry

Chapter 13    Appendix



LIST OF TABLES

Table 1        Oral Cancer Treatment Industry Synopsis, 2017 – 2023

Table 2        Global Oral Cancer Treatment Market Estimates and Forecast, 2017 – 2023, (USD Million)

Table 3        Global Oral Cancer Treatment Market by Region, 2017 – 2023, (USD Million)

Table 4        Global Oral Cancer Treatment Market by Type, 2017 – 2023, (USD Million)

Table 5        Global Oral Cancer Treatment Market by Treatment, 2017 – 2023, (USD Million)

Table 6        Global Oral Cancer Treatment Market by End Users, 2017 – 2023, (USD Million)

Table 7        North America Oral Cancer Treatment Market by Type, 2017 – 2023, (USD Million)

Table 8        North America Oral Cancer Treatment by Treatment, 2017 – 2023, (USD Million)

Table 9        North America Oral Cancer Treatment by End Users, 2017 – 2023, (USD Million)

Table 10    U.S. Oral Cancer Treatment Market by Type, 2017 – 2023, (USD Million)

Table 11    U.S. Oral Cancer Treatment Market by Treatment, 2017 – 2023, (USD Million)

Table 12    U.S. Oral Cancer Treatment Market by End Users, 2017 – 2023, (USD Million)

Table 13    Canada Oral Cancer Treatment Market by Type, 2017 – 2023, (USD Million)

Table 14    Canada Oral Cancer Treatment Market by Treatment, 2017 – 2023, (USD Million)

Table 15    Canada Oral Cancer Treatment Market by End Users, 2017 – 2023, (USD Million)

Table 16    South America Oral Cancer Treatment Market by Type, 2017 – 2023, (USD Million)

Table 17    South America Oral Cancer Treatment Market by Treatment, 2017 – 2023, (USD Million)

Table 18    South America Oral Cancer Treatment Market by End Users, 2017 – 2023, (USD Million)

Table 19    Europe Oral Cancer Treatment Market by Type, 2017 – 2023, (USD Million)

Table 20    Europe Oral Cancer Treatment Market by Treatment, 2017 – 2023, (USD Million)

Table 21    Europe Oral Cancer Treatment Market by End Users, 2017 – 2023, (USD Million)

Table 22    Western Europe Oral Cancer Treatment Market by Type, 2017 – 2023, (USD Million)

Table 23    Western Europe Oral Cancer Treatment Market by Treatment, 2017 – 2023, (USD Million)

Table 24    Western Europe Oral Cancer Treatment Market by End Users, 2017 – 2023, (USD Million)

Table 25    Eastern Europe Oral Cancer Treatment Market by Type, 2017 – 2023, (USD Million)

Table 26    Eastern Europe Oral Cancer Treatment Market by Treatment, 2017 – 2023, (USD Million)

Table 27    Eastern Europe Oral Cancer Treatment Market by End Users, 2017 – 2023, (USD Million)

Table 28    Asia Pacific Oral Cancer Treatment Market by Type, 2017 – 2023, (USD Million)

Table 29    Asia Pacific Oral Cancer Treatment Market by Treatment, 2017 – 2023, (USD Million)

Table 30    Asia Pacific Oral Cancer Treatment Market by End Users, 2017 – 2023, (USD Million)

Table 31    Middle East & Africa Oral Cancer Treatment Market by Type, 2017 – 2023, (USD Million)

Table 32    Middle East & Africa Oral Cancer Treatment Market by Treatment, 2017 – 2023, (USD Million)

Table 33    Middle East & Africa Oral Cancer Treatment Market by End Users, 2017 – 2023, (USD Million)

LIST OF FIGURES

Figure 1    Research Process

Figure 2    Segmentation for Global Oral Cancer Treatment Market

Figure 3    Market Dynamics for Global Oral Cancer Treatment Market

Figure 4    Global Oral Cancer Treatment Market Share, by Type 2016

Figure 5    Global Oral Cancer Treatment Market Share, by Treatment 2016

Figure 6    Global Oral Cancer Treatment Market Share, by End Users, 2016

Figure 7    Global Oral Cancer Treatment Market Share, by Region, 2016

Figure 8    North America Oral Cancer Treatment Market Share, by Country, 2016

Figure 9    Europe Oral Cancer Treatment Market Share, by Country, 2016

Figure 10    Asia Pacific Oral Cancer Treatment Market Share, by Country, 2016

Figure 11    Middle East & Africa Oral Cancer Treatment Market Share, by Country, 2016

Figure 12    Global Oral Cancer Treatment Market: Company Share Analysis, 2016 (%)

Figure 13    Bristol-Myers Squibb Company: Key Financials

Figure 14    Bristol-Myers Squibb Company: Segmental Revenue

Figure 15    Bristol-Myers Squibb Company: Geographical Revenue

Figure 16    Qilu Pharmaceutical Co., Ltd.: Key Financials

Figure 17    Qilu Pharmaceutical Co., Ltd.: Segmental Revenue

Figure 18    Qilu Pharmaceutical Co., Ltd.: Geographical Revenue

Figure 19    Teva Pharmaceutical Industries Ltd.: Key Financials

Figure 20    Teva Pharmaceutical Industries Ltd.: Segmental Revenue

Figure 21    Teva Pharmaceutical Industries Ltd.: Geographical Revenue

Figure 22    Eli Lilly and Company.: Key Financials

Figure 23    Eli Lilly and Company.: Segmental Revenue

Figure 24    Eli Lilly and Company.: Geographical Revenue

Figure 25    F. Hoffmann-La Roche Ltd: Key Financials

Figure 26    F. Hoffmann-La Roche Ltd: Segmental Revenue

Figure 27    F. Hoffmann-La Roche Ltd: Geographical Revenue

Figure 28    Merck & Co., Inc.: Key Financials

Figure 29    Merck & Co., Inc.: Segmental Revenue

Figure 30    Merck & Co., Inc.: Geographical Revenue

Figure 31    Novartis AG: Key Financials

Figure 32    Novartis AG: Segmental Revenue

Figure 33    Novartis AG: Geographical Revenue

Figure 34    Pfizer Inc.: Key Financials

Figure 35    Pfizer Inc.: Segmental Revenue

Figure 36    Pfizer Inc.: Geographical Revenue